Article
Gene expression dynamics following mithramycin treatment: A possible model for post-chemotherapy cognitive impairment.
Clinical and experimental pharmacology & physiology - 1 Oct 2018
Asor Eyal, Ben-Shachar Dorit
Abstract excerpt
Chemotherapy-induced cognitive changes is a major burden on a substantial number of cancer survivors. The mechanism of this sequel is unknown. In this study, we followed long-term effects of early in life mithramycin (MTR) treatment on behaviour and on the normal course of alterations of gene expression in brain. Between post-natal days (PND) 7 and 10, male rats were divided into 2 groups, 1 receiving MTR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
